1. Home
  2. CIO vs NGNE Comparison

CIO vs NGNE Comparison

Compare CIO & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo City Office REIT Inc.

CIO

City Office REIT Inc.

HOLD

Current Price

$6.99

Market Cap

278.5M

Sector

Real Estate

ML Signal

HOLD

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$18.53

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIO
NGNE
Founded
2013
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
278.5M
327.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CIO
NGNE
Price
$6.99
$18.53
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
N/A
$38.50
AVG Volume (30 Days)
347.5K
165.8K
Earning Date
02-19-2026
11-13-2025
Dividend Yield
4.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$163,795,000.00
N/A
Revenue This Year
$0.32
N/A
Revenue Next Year
$3.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.19
$6.88
52 Week High
$7.01
$37.27

Technical Indicators

Market Signals
Indicator
CIO
NGNE
Relative Strength Index (RSI) 67.11 39.16
Support Level $6.94 $19.28
Resistance Level $6.97 $22.99
Average True Range (ATR) 0.01 1.48
MACD 0.00 0.05
Stochastic Oscillator 90.00 8.43

Price Performance

Historical Comparison
CIO
NGNE

About CIO City Office REIT Inc.

City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: